Filter
95
Filtered Results: 95
Text search:
heterologous
Featured
Recommendations
9
New Publications
14
Language
Document type
Guidelines
38
No document type
32
Studies & Reports
10
Manuals
5
Fact sheets
5
Strategic & Response Plan
3
Situation Updates
1
Infographics
1
Countries / Regions
Brazil
8
India
6
Argentina
5
Latin America and the Carribbean
3
South Africa
3
Nigeria
2
Mozambique
2
Africa
2
Paraguay
2
Bolivia
2
Russia
2
Chile
1
Philippines
1
Tanzania
1
Germany
1
East and Southern Africa
1
Uganda
1
Indonesia
1
Ecuador
1
Authors & Publishers
Publication Years
Category
Guidelines
23
COVID-19
22
Rabies
4
Policies
3
Virology
2
Malaria
2
Paediatrics
1
Clinical Training
1
Hematology
1
Vaccine-preventable Diseases
1
Yellow Fever
1
Policies & Guidelines HIV & TB
1
Drugs & Medical Equipment
1
Studies & Reports
1
NTDs & Others
1
Dengue
1
Parasitology
1
Disease Prevention & Control
1
Toolboxes
Country specific documents
13
Inactivated COVID-19 Vaccines
10
Booster Doses
9
Immunization Guidelines
8
Biontech/Pfizer Comirnaty
7
Vaxzevria (Astra Zeneca)
6
Moderna
4
Access & Strategy
3
Research & Access
3
Fair Allocation & Ethical Aspects
2
Johnson & Johnson
2
Covaxin
2
Clinical Aspects & Diagnostics
2
Zika
2
Laboratory & Diagnostics
2
Assessment & Studies
1
Vaccines & Immunization
1
Yellow Fever
1
Pediatrics
1
Dengue
1
HIV
1
TB
1
IACAPAP International Association for Child and Adolescent Psychiatry and Allied Professions
1
Children/Adolescents Mental Disorders
1
Vaccination
1
Children
1
Clinical Guidelines
1
COVID-19
1
For Parents & Children
1
For Older People
1
Communication Material
1
Dashboards & Resource Platforms
1
SARS-CoV-2 Variants
1
Vector-based Vacines General
1
Sputnik V
1
Chile
1
Traditional & Herbal Medicines
1
Zoonoses
1
MOPX - Monkeypox
1
Clinical Aspects & Diagnostics
1
Statistics & Facts
1
Studies & Reports
1
Studies & Reports
1
General Information & Methodology
1
Neurological Disorders
1
Food & Nutrition
1
Neurological disorders, Others
1
Overview
16 Dec 2021. This interim guidance pertains to heterologous primary and heterologous boosting schedules of Covid-19 vaccines. It focuses on heterologous schedules combining multiple vaccine platforms (e.g. a vectored vaccine followed by an mRNA vaccine).
Clinical Medicine
JCI Insight. 2017;2(7):e91963.
This algorithm is addressed to laboratories
with established capacity(molecular, antigenic and/orserological) to detect dengue (DENV), Zika (ZIKV), and chikungunya(CHIKV) as part of the differential diagnosis for arborviruses. A BSL2 containment level is required to handle suspected samples.
Interim recommendations for use of the inactivated COVID-19 vaccine, CoronaVac, developed by Sinovac
These WHO interim recommendations for use of the Sinovac-CoronaVac were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
This document has been updat...
Временное руководство (Первый выпуск 24 мая 2021 г., Обновлено 21 октября 2021 г., Обновлено 15 марта 2022 г.
21 January 2022
The overall threat posed by Omicron largely depends on four key questions: (i) how transmissible the variant is; (ii) how well vaccines and prior infection protect against infection, transmission, clinical disease and death; (iii) how virulent the variant is compared to other varian...
Este algoritmo está dirigido a aquellos laboratorios que cuentan con capacidad instalada para la detección (molecular, antigénica y/o serológica) de dengue (DENV), Zika (ZIKV) y chikungunya(CHIKV),y como parte del diagnóstico diferencial para Arbovirus. Para la manipulación de muestras sosp...
Guidelines for the Vaccination Scheme against
COVID 19: Booster Dose Health Personnel
Additional dose of the primary vaccination against COVID-19: Technical Guidelines
Campaña Nacional de Vacunación contra la COVID-19
La evidencia disponible a nivel internacional sobre el uso de un segundo refuerzo muestra una mayor duración de la respuesta inmune y una disminución de la internación y la mortalidad por COVID 19 en la población de adultos mayores y huéspedes inmunocomprometidos. Por otra parte, el personal de...
New edition
Vaccins antirabiques: Note de synthèse de l’OMS – avril 2018
Weekly epidemiological record / Relevé épidémiologique hebdomadaire
20 APRIL 2018, 93th YEAR / 20 AVRIL 2018, 93e ANNÉE
Weekly epidemiological record / Relevé épidémiologique hebdomadaire
20 APRIL 2018, 93th YEAR / 20 AVRIL 2018, 93e ANNÉE
